Will 2020 look like the year before? The current global crisis complicates any prediction. What is certain, however, is the strong performance of Bitcoin in 2019. For CB Insights, “Bitcoin was king” until the coronavirus and the movement of liquidation of crypto assets by investors.
In its study Blockchain Report 2020, the research firm pointed out that the value of this cryptocurrency has almost doubled in the last year. However, it pointed out that media coverage was much less than in the past.
Discover the latest news from the crypto sector and read the most important economic news with the Born2Invest mobile app.
2020, the first major crisis and test year for Bitcoin?
However, for financial players, including traditional ones, Bitcoin’s top quality is its performance in terms of yield. In fact, Goldman Sachs has identified Bitcoin as the best performing asset in 2019.
Like the traditional financial market, the prices of crypto-currencies collapsed in the wake of the coronavirus crisis, shattering the concept of safe havens in the process. At least that is the short-term analysis.
However, 2020 might not be such a catastrophic year, since, after the plunge, Bitcoin’s value returned to growth and stabilized at around $6,000. On March, 13th, at its lowest observed price ($3,932), Bitcoin was showing losses of about 49% compared to its price of ~$7,700 at the beginning of the day. The digital coin was also trading at its lowest level in almost a year.
The crisis could be an opportunity for Bitcoin (and crypto-currency supporters) to demonstrate its value as a safe haven. The performance of this asset was not the only noteworthy element of 2019 for CB Insights, which is observing a clear change in the methods of financing companies in the sector.
Two years earlier, ICOs had enabled players to raise $7.8 billion. However, the boom has now passed. In 2019, their amount fell by 95% to $371 million. However, to raise funding, companies have been able to rely on more traditional methods, such as private equity.
$2.7 billion in equity financing
These funds have indeed taken over, the study noted, with $2.79 billion raised from these investors. However, it was not enough to compensate for the collapse of financing (-30% over one year). A return of ICOs, including in France, would not be totally outlawed.
CB Insights noted a certain openness on the part of regulators, but within a stricter framework and under the supervision of the competent authorities, such as the SEC in the United States. This favorable outcome could be explained by the availability of more efficient tools for monitoring crypto networks, including those of Chainalysis, Elliptic or CypherTrace.
Nevertheless, “although the United States has shown openness in some areas of cryptography, it represses others,” the firm pointed out in its annual study.
Finally, regulation may not be the main challenge for crypto players. The Blockchain Report reminded that the low use of dApps, the lack of network interoperability and the high volatility are “still obstacles to the massive adoption of crypto tools.”
However, 2020 is expected to be marked by the “explosion of blockchain service providers”, in particular exchanges and depositories. The objective for businesses is to be competitive by offering value-added and high-margin services.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in CRYPTONAUTE, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Mediquo Is Committed to the International Market and Aims to Double Sales in 2024
Mediquo makes it possible for any healthcare professional to care for their patients via chat. Last April, the Catalan company...
Why the Agrifood Industry in Morocco is a Strategic Challenge
The organization of an international agrifood trade show in Morocco would be a key lever for stimulating local exports and...
What Fintech Trends Will Mark 2024 in Latin America
Fintech companies have an important role to play in the development of the Latin American economy. In 2024, the sector...
Hi-Tech Buoy to Clean Up the Seas Created by Jelter
Microplastic fragments range in size from 0.33 to 5 mm and can cause devastating consequences for entire ecosystems. They are...
f2o Sports Announced that Its Crowdfunding Campaign Has Started
f2o Sports is a global company founded in the heart of Silicon Valley, California, with the purpose of changing the...
Business1 week ago
This Quant Beat the S&P 500 By 475% — Get Access @ 30% Off This Black Friday
Crypto2 days ago
Greed Dominates Bitcoin Market Again After Two Years
Biotech2 weeks ago
Eli Lilly Receives Validation of Its Anti-Obesity Drug in Europe
Biotech1 week ago
Vive Biotech Contacts Santander to Find a Buyer